Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma
Phase 2
Completed
- Conditions
- Eosinophilic AsthmaBronchial Asthma
- Interventions
- Drug: PlaceboDrug: XC8 100 mg
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- Chemlmmune Therapeutics LLC
- Target Recruit Count
- 70
- Registration Number
- NCT04674137
- Locations
- 🇷🇺
Federal State Autonomous Educational Institution of Higher Education "Immanuel Kant Baltic Federal University"of Ministry of Health of the Russian Federation, Kaliningrad, Russian Federation
🇷🇺Federal State Autonomous Educational Institution of Higher Education "Kazan (Volga region) Federal University", Kazan, Russian Federation
🇷🇺Federal State Educational Institution of Higher Education "Kazan State Medical University" of the Ministry of Health of the Russian Federation, Kazan, Russian Federation
News
No news found